All Articles
1 min read
Стартапы2026年9月23日
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Marina Temkin·TechCrunch — AI
Original SourceKey Takeaways
- 01.The round valued the AI biotech at $2 billion
- 02.It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
This material is provided as an extended analytical summary.
Read full article at sourceAggregated within AI Qazaqstan national intelligence stream with author attribution.
Related Intelligence
All stories →Стартапы1 мин
OpenAI 如何将其编码工具转变为 dots，一个始终在线的个人助手
负责 dots 的 OpenAI 高管 Alexander Embiricos 从不想与别人的 AI 代理开会。
TechCrunch — AI
Исследования1 мин
It's happening...
One of the most controversial companies in history just filed to go public. And yes, we're talking about Anthropic. The same company that says there's a greater than 10% chance AI kills all of humanity is also simultaneously one of the best built businesses of all time. And in…
YouTube — Matthew Berman
База знаний1 мин
新的全栈设计师
今天，Marvin Schwaibold 加入了我的行列，他是 Shopify 产品设计工作室的负责人。他将向我们展示他的幕后制作过程，>> [音乐] >> 我们将看到他如何使用最新的人工智能工具将他的设计变为现实，然后回顾一些观众提交的……
YouTube — Y Combinator AI